Dendritic cell therapy combined with surgery in mesothelioma (ENSURE)
76712
Phase 1 other active
Quick answer
Dendritic cell therapy combined with surgery in mesothelioma (ENSURE) for Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy. is a Phase 1 program (other) at Disc Medicine with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Disc Medicine
- Indication
- Adult patients diagnosed with resectable epithelioid MPM, following first-line chemotherapy.
- Phase
- Phase 1
- Modality
- other
- Status
- active